During the past decade, Weill Cornell Medical Center, Comprehensive Epilepsy Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Weill Cornell Medical Center, Comprehensive Epilepsy Center" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Dartmouth-Hitchcock Medical Center" with 1 trials as a collaborator, "Emory University" with 1 trials as a collaborator and "Johns Hopkins University" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Weill Cornell Medical Center, Comprehensive Epilepsy Center" are "Epilepsy" (3 trials), "Menopause" (1 trials) and "Refractory Partial Onset Seizures" (1 trials). Many other conditions were trialed in "Weill Cornell Medical Center, Comprehensive Epilepsy Center" in a lesser frequency.

Most popular intervention types in "Weill Cornell Medical Center, Comprehensive Epilepsy Center" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rufinamide" (2 trials), "Matched Placebo Lozenges" (1 trials), "Placebo" (1 trials), "Progesterone Lozenges" (1 trials) and "prempro" (1 trials). Other intervention names were less common.

The vast majority of trials in "Weill Cornell Medical Center, Comprehensive Epilepsy Center" are 2 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Weill Cornell Medical Center, Comprehensive Epilepsy Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Weill Cornell Medical Center, Comprehensive Epilepsy Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Weill Cornell Medical Center, Comprehensive Epilepsy Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".